VERLUCO
Holdings
own accounts to 30-06-2023This companyVERLUCO1 holding, 1 country
accounts to 30-06-2023
Belgium 1 Equity Result
- BE Extra Pharma98% €559,094 result €97,780
Source: list of holdings in its own 30-06-2023 accounts. Every holding stands with its own latest accounts.
Holdings and subsidiaries
1 holdingHoldings 1
Share, source and own figures per holding (1)
- EXTRA-PHARMAsubsidiaryEquity €559,094 Profit of €97,780 in 2025 (profit of €413,070 in 2024) Checked score 55Sourceown accounts 30-06-202398%
Holdings through the years 2007 to 2023
| Name | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EXTRA-PHARMA | 98% | ||||||||||||||||
| MEDIVITA PARTICIPATIONS | 32.97% | 43.18% | 43.2% | ||||||||||||||
| CACHET FINANCE | 25% | ||||||||||||||||
| PHI-BIS | 50% | ||||||||||||||||
| LAMBRECHTS FINANCE | 25% | ||||||||||||||||
| PHI FINANCE | 25% | ||||||||||||||||
Source: list of holdings in its own accounts
Connections & network
The network lets you explore the ties of VERLUCO.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.